Alpha-lactose reverses liver injury via blockade of Tim-3-mediated CD8 apoptosis in sepsis.

@article{Wei2018AlphalactoseRL,
  title={Alpha-lactose reverses liver injury via blockade of Tim-3-mediated CD8 apoptosis in sepsis.},
  author={Zhengping Wei and Pingfei Li and Yao Yao and Hai Deng and Shengwu Yi and Cong Zhang and Han Wu and Xiuxiu Xie and Minghui Xia and Ran He and Xiang-Ping Yang and Zhao-Hui Tang},
  journal={Clinical immunology},
  year={2018},
  volume={192},
  pages={
          78-84
        }
}
New paradigm of immune checkpoint immunotherapy in sepsis
TLDR
The roles of costimulatory molecules, regulatory T-cells, and neuroendocrine factors in the immunosenescence of sepsis are discussed, aiming to build a novel understanding of this disorder by exploring potential targets for immune therapy.
Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection
TLDR
A novel mechanism by which up-regulated Tim-3 expression induced the depletion and dysfunction of NKT cells in COVID-19 patients is described, which has possible implications for the prediction of severity and prognosis in CO VID-19 but also provides a link between N KT cells and future new therapeutic strategies in SARS-CoV-2 infection.
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?
TLDR
The present review provides a complete analysis of the pharmaceutical and galectin-related biological functions of (α/β)-lactose, focusing on the capacity of lactose and Gal-9 to modulate both the TIM-3/Gal-9 and PD-1/PD-L1 immune checkpoints in oncology.
Regulation of hippocampal neuronal apoptosis and autophagy in mice with sepsis‐associated encephalopathy by immunity‐related GTPase M1
TLDR
The goal was to investigate the role of immunity‐related GTPase M1 (IRGM1) in SAE and its underlying mechanism and to establish a causal link between immunity and encephalopathy.

References

SHOWING 1-10 OF 38 REFERENCES
a-Lactose Improves the Survival of Septic Mice by Blockade of TIM-3 Signaling to Prevent NKT Cell Apoptosis and Attenuate Cytokine Storm
TLDR
It is shown that T-cell immunoglobulin and mucin domain 3 (Tim-3) expression in NKT cells is elevated in experimental mice during sepsis, and administration of &agr;-lactose to block Tim-3 signaling pathway significantly improved the survival of septic mice and could be a promising immunomodulatory agent in the treatment of sepsi.
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1
TLDR
Although there was no overall effect on lymphocytes from critically ill nonseptic patients (considered as a group), certain individual patients did exhibit significant loss of B and CD4 T cells in sepsis, which is especially significant because it occurs during life-threatening infection, a state in which massive lymphocyte clonal expansion should exist.
IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
TLDR
In conclusion, IL-15 prevents two immunopathologic hallmarks of sepsis, namely, apoptosis and immunosuppression, and improves survival in two different models ofsepsis.
Delayed administration of anti‐PD‐1 antibody reverses immune dysfunction and improves survival during sepsis
TLDR
Delayed administration of anti‐PD‐1 antibody, an important therapeutic advantage, was effective in sepsis and adds to the growing body of evidence that modulation of the positive and negative costimulatory pathways on immune cells represents a viable therapeutic approach in reversing immunosuppression and improving sepsi survival.
CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL.
TLDR
It is reported that although truncating Fas-FasL signaling ameliorates many untoward effects of sepsis, the pathological mode of action is distinct at the tissue level.
Persistent inflammation and T cell exhaustion in severe sepsis in the elderly
TLDR
Persistent inflammation and T cell exhaustion may be associated with decreased survival in elderly patients and mice after sepsis.
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
TLDR
In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages.
Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance
TLDR
The data indicate that the Tim-3 pathway provides an important mechanism to down-regulate TH1-dependent immune responses and to facilitate the development of immunological tolerance.
...
...